Rheumatology Author Dr Stanley Cohen: Fenebrutinib
Jun 23, 2020
12:23
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Stanley Cohen from Southwestern Medical School.
Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Dr Stanley Cohen discusses a phase 2 trial of BTK inhibitor, fenebrutinib.
